Doctor profile · Federal record
Dr. Peyman Salimi-Tari, M.D.
Specialist (CMS: Hematology/Oncology) · Hematology & Oncology Physician · Fountain Valley, CA
- NPI 1639238371
- Accepts Medicare
- 24 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
11180 Warner Ave Ste 351
Fountain Valley, CA 927087516
(714) 698-0300
fax (714) 698-0313
Credentials & registration
- NPI registered
- December 2006 — 20 yrs on file
- Profile last updated
- May 15, 2019
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 174400000X — NUCC code
- State license (1)
- California #A104791
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1639238371. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,098
Distinct HCPCS
10
Medicare allowed
$165,417
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 1,548 | 16 | $0 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,126 | 13 | $0 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 386 | 126 | $194 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 240 | 30 | $152 | |
96367 |
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 144 | 18 | $33 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 138 | 76 | $138 | |
96375 |
Injection of additional new drug or substance into vein | 128 | 17 | $18 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 100 | 38 | $125 | |
J1200 |
Injection, diphenhydramine hcl, up to 50 mg | 96 | 13 | $1 | |
J3489 |
Injection, zoledronic acid, 1 mg | 77 | 13 | $8 |
In context: peer comparison
Among 8 peers in Fountain Valley Specialist, average services per provider: 359. This provider delivers 11× the peer median.Open Payments
Industry payments received
All-time total
$9,338
Transactions
246
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 35 | $1,500.73 | |
| Alexion Pharmaceuticals, INC. | 18 | $607.01 | |
| AstraZeneca Pharmaceuticals Lp | 22 | $488.46 | |
| Merck Sharp & Dohme LLC | 17 | $466.96 | |
| Eisai INC. | 18 | $423.58 | |
| Takeda Pharmaceuticals U.S.A., INC. | 15 | $407.24 | |
| Pfizer INC. | 18 | $385.52 | |
| Janssen Biotech, INC. | 13 | $364.80 | |
| Incyte Corporation | 16 | $338.35 | |
| Celgene Corporation | 22 | $332.40 | |
| Abbvie INC. | 18 | $294.74 | |
| Puma Biotechnology, INC. | 9 | $245.29 | |
| Stemline Therapeutics INC. | 8 | $220.77 | |
| Gilead Sciences, INC. | 9 | $214.12 | |
| BeiGene USA, INC. | 8 | $211.59 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
535
Patients
30
Total drug cost
$1,483,893
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Sodium Chloride (0.9 % Sodium Chloride) | Brand | 72 | 0 | $286 |
| Ondansetron Hcl (Ondansetron Hcl/Pf) | Brand | 51 | 0 | $125 |
| Dexamethasone Sodium Phosphate | Generic | 46 | 0 | $154 |
| Letrozole | Generic | 45 | 18 | $1,420 |
| Zarxio (Filgrastim-Sndz) | Brand | 43 | 0 | $56,936 |
| Prednisone | Generic | 38 | 12 | $294 |
| Abiraterone Acetate | Generic | 34 | 0 | $231,146 |
| Diphenhydramine Hcl | Generic | 33 | 0 | $74 |
| Famotidine (Famotidine/Pf) | Brand | 29 | 0 | $26 |
| Tagrisso (Osimertinib Mesylate) | Brand | 27 | 0 | $544,080 |
Hospital affiliations
Frequently asked questions
What is Dr. Peyman Salimi-Tari's medical specialty?
Dr. Peyman Salimi-Tari practices Specialist in Fountain Valley, CA.
Where does Dr. Peyman Salimi-Tari practice?
Dr. Peyman Salimi-Tari practices at 11180 Warner Ave Ste 351, Fountain Valley, CA 927087516. Office phone: 7146980300.
What is Dr. Peyman Salimi-Tari's NPI?
Dr. Peyman Salimi-Tari's National Provider Identifier (NPI) is 1639238371, issued by NPPES.
Does Dr. Peyman Salimi-Tari accept Medicare assignment?
Yes. Dr. Peyman Salimi-Tari accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Peyman Salimi-Tari commonly perform?
Top Medicare-reported procedures in 2023: Injection, ondansetron hydrochloride, per 1 mg (HCPCS J2405); Injection, dexamethasone sodium phosphate, 1 mg (HCPCS J1100); Established patient office or other outpatient visit (HCPCS 99215). Source: CMS Medicare Physician & Other Practitioners file.